Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2022 Oct 17

PMID 36248415

Authors

Fei Chen

Xing Peng

Zhipeng Teng

Haibo Long

Haibo Wu

Affiliations

Soon will be listed here.

Abstract

Glioma is the most commonly occurring primary neuroepithelial neoplasm. Long noncoding RNAs (lncRNAs) are emerging as pivotal modulators of gene expression in the immune system and play critical roles in the growth, progression, and immune response of carcinomas. In this study, we performed univariate Cox regression analysis on survival data from TCGA and identified 20 prognostic lncRNAs. Moreover, we revealed that these prognosis-related lncRNAs (PRLnc) were dysregulated in glioma. Furthermore, we constructed a signature based on the expression levels of these prognosis-related lncRNAs based on 13 prognostic lncRNAs, including AGAP2-AS1, CYTOR, MIR155HG, LINC00634, HOTAIRM1, SNHG18, LINC01841, LINC01842, LINC01426, MIR9-3HG, TMEM220-AS1, LINC00641, LINC01270, and LINC01503. The Kaplan-Meier curves show that high-risk patients had a shorter survival time. Finally, the glioma samples were classified into 2 subgroups based on the median expression of prognosis-related lncRNAs in each sample. In summary, these findings suggest that PRLnc is associated with tumor-infiltrating immune cells in glioma and that subtype 2 patients may respond more positively to immunotherapy.

Citing Articles

Retracted: Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma.

And Alternative Medicine E Evid Based Complement Alternat Med. 2023; 2023:9761231.

PMID: 37388089 PMC: 10307450. DOI: 10.1155/2023/9761231.

Molecular subtypes and a prognostic model for hepatocellular carcinoma based on immune- and immunogenic cell death-related lncRNAs.

He M, Gu W, Gao Y, Liu Y, Liu J, Li Z Front Immunol. 2022; 13:1043827.

PMID: 36479122 PMC: 9720162. DOI: 10.3389/fimmu.2022.1043827.

References

Lin L, Cai J, Jiang C . Recent Advances in Targeted Therapy for Glioma. Curr Med Chem. 2016; 24(13):1365-1381. DOI: 10.2174/0929867323666161223150242. View

Pang W, Zhai M, Wang Y, Li Z . Long noncoding RNA SNHG16 silencing inhibits the aggressiveness of gastric cancer via upregulation of microRNA-628-3p and consequent decrease of NRP1. Cancer Manag Res. 2019; 11:7263-7277. PMC: 6682761. DOI: 10.2147/CMAR.S211856. View

Zhou X, Dai H, Zhang H, Zhu J, Hu H . Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma. Biomed Res Int. 2022; 2022:2056913. PMC: 9352484. DOI: 10.1155/2022/2056913. View

Cao J, Tang Z, Su Z . Long non-coding RNA LINC01426 facilitates glioblastoma progression via sponging miR-345-3p and upregulation of VAMP8. Cancer Cell Int. 2020; 20:327. PMC: 7372762. DOI: 10.1186/s12935-020-01416-3. View

Zhang Y, Xiao Y, Li G, Gong F, Zhang X, Hou K . Long non-coding RNAs as epigenetic mediator and predictor of glioma progression, invasiveness, and prognosis. Semin Cancer Biol. 2020; 83:536-542. DOI: 10.1016/j.semcancer.2020.08.016. View

Wang H, Sheng Z, Dai L . Long non-coding RNA LINC01503 predicts worse prognosis in glioma and promotes tumorigenesis and progression through activation of Wnt/β-catenin signaling. Eur Rev Med Pharmacol Sci. 2019; 23(4):1600-1609. DOI: 10.26355/eurrev_201902_17119. View

Zhang Y, Sui R, Chen Y, Liang H, Shi J, Piao H . Long noncoding RNA MT1JP inhibits proliferation, invasion, and migration while promoting apoptosis of glioma cells through the activation of PTEN/Akt signaling pathway. J Cell Physiol. 2019; 234(11):19553-19564. DOI: 10.1002/jcp.28553. View

Wang S, Wang H, Zhao C, Li R . Long noncoding RNA LINC01426 promotes glioma progression through PI3K/AKT signaling pathway and serves as a prognostic biomarker. Eur Rev Med Pharmacol Sci. 2018; 22(19):6358-6368. DOI: 10.26355/eurrev_201810_16047. View

Shi J, Zhang Y, Qin B, Wang Y, Zhu X . Long non-coding RNA LINC00174 promotes glycolysis and tumor progression by regulating miR-152-3p/SLC2A1 axis in glioma. J Exp Clin Cancer Res. 2019; 38(1):395. PMC: 6731586. DOI: 10.1186/s13046-019-1390-x. View

10.

Li X, Meng Y . Survival analysis of immune-related lncRNA in low-grade glioma. BMC Cancer. 2019; 19(1):813. PMC: 6697914. DOI: 10.1186/s12885-019-6032-3. View

11.

Li Y, Jiang T, Zhou W, Li J, Li X, Wang Q . Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers. Nat Commun. 2020; 11(1):1000. PMC: 7035327. DOI: 10.1038/s41467-020-14802-2. View

12.

Liu Z, Lu C, Hu H, Cai Z, Liang Q, Sun W . LINC00909 promotes tumor progression in human glioma through regulation of miR-194/MUC1-C axis. Biomed Pharmacother. 2019; 116:108965. DOI: 10.1016/j.biopha.2019.108965. View

13.

Brahic M, Bureau J, Michiels T . The genetics of the persistent infection and demyelinating disease caused by Theiler's virus. Annu Rev Microbiol. 2005; 59:279-98. DOI: 10.1146/annurev.micro.59.030804.121242. View

14.

Xu H, Zheng Q, Zhu J, Xie Z, Cheng H, Li P . A Deep Learning Model Incorporating Knowledge Representation Vectors and Its Application in Diabetes Prediction. Dis Markers. 2022; 2022:7593750. PMC: 9391170. DOI: 10.1155/2022/7593750. View

15.

Pang Q, Ge J, Shao Y, Sun W, Song H, Xia T . Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance. Tumour Biol. 2014; 35(6):5441-7. DOI: 10.1007/s13277-014-1709-3. View

16.

Jiang H, Cui Y, Wang J, Lin S . Impact of epidemiological characteristics of supratentorial gliomas in adults brought about by the 2016 world health organization classification of tumors of the central nervous system. Oncotarget. 2016; 8(12):20354-20361. PMC: 5386767. DOI: 10.18632/oncotarget.13555. View

17.

Qi Y, Wang Z, Wu F, Yin B, Jiang T, Qiang B . Long noncoding RNA HOXD-AS2 regulates cell cycle to promote glioma progression. J Cell Biochem. 2018; 120(5):8343-8351. DOI: 10.1002/jcb.28117. View

18.

Gu J, Liu Y, Kyritsis A, Bondy M . Molecular epidemiology of primary brain tumors. Neurotherapeutics. 2009; 6(3):427-35. PMC: 5084179. DOI: 10.1016/j.nurt.2009.05.001. View

19.

Momtazmanesh S, Rezaei N . Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review. Front Oncol. 2021; 11:712786. PMC: 8311560. DOI: 10.3389/fonc.2021.712786. View

20.

Hoshide R, Jandial R . 2016 World Health Organization Classification of Central Nervous System Tumors: An Era of Molecular Biology. World Neurosurg. 2016; 94:561-562. DOI: 10.1016/j.wneu.2016.07.082. View